REQUEST A DEMO
Total
USD $0.00
Search more companies

Vitrotest Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Vitrotest Sp. z o.o. Profile Updated: May 31, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2019 Available in: English & Polish Download a sample report

Vitrotest Sp. z o.o. is an enterprise in Poland, with the main office in Gdansk. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on September 11, 2014. It currently has a total number of 4 (2015) employees. Its total assets decreased by 34.85% over the same period.

Headquarters
Ul. Grunwaldzka 472
Gdansk; Pomorskie; Postal Code: 80-309

Contact Details: Purchase the Vitrotest Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Vitrotest Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Vitrotest Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Vitrotest Sp. z o.o. report to view the information.
Incorporation Date:
September 11, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Vitrotest Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
439520.33%
Operating profit (EBIT)
-95.41%
Net Profit (Loss) for the Period
-95.41%
Total assets
-34.85%
Total equity
-1.59%
Return on Equity (ROE)
33.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?